Small Bowel Lesions and Bleeding Risk in Hemodialysis Patients: A Narrative Review
ABSTRACT Background Gastrointestinal bleeding is very common among hemodialysis patients. This high bleeding risk is caused by uremic platelet dysfunction, vascular fragility, intradialytic hemodynamic instability, and widespread antithrombotic therapy.
Andreas Smyrlis +3 more
wiley +1 more source
Synchronous AML and pancreatic neuroendocrine neoplasm, both successfully treated with somatostatin analogs and decitabine. [PDF]
Ehsanullah S, Trikalinos NA.
europepmc +1 more source
Abstract Liver transplantation (LT) may offer survival or symptomatic benefit for highly selected patients with advanced, well‐differentiated small‐intestinal or pancreatic neuroendocrine tumours and unresectable liver‐dominant metastases. However, its role remains controversial, as LT is rarely curative, recurrence is common, and benefits must be ...
Peter Stålberg +11 more
wiley +1 more source
Myenteric nerve cell bodies in the human gastric corpus were divided into 12 classes by the combinatorial expression of 15 neuronal markers, using multiplexed immunohistochemistry (1084 neurons from 7 individuals). Baskets of axonal varicosities from vagal or enteric sources were analyzed to detect targeted patterns of connectivity ...
M. E. Johnson +10 more
wiley +1 more source
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? [PDF]
Merola E +16 more
europepmc +1 more source
Beyond Tumor Control in Sporadic Neuroendocrine Tumor: Metabolic and Bone Health During Treatment with Somatostatin Analogs. [PDF]
Modica R +7 more
europepmc +1 more source
Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center. [PDF]
Liu J +7 more
europepmc +1 more source
Somatostatin analogs in neuroendocrine tumors with Ki-67 index of ≥10. [PDF]
Braegelmann J +6 more
europepmc +1 more source
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs. [PDF]
Lenotti E +9 more
europepmc +1 more source
Somatostatin Analogs Versus Active Surveillance in Small Pancreatic Neuroendocrine Tumors. [PDF]
Maratta MG +14 more
europepmc +1 more source

